in a prospective randomized study , the chemotherapeutic combination of high-dose methotrexate-citrovorum factor rescue plus cyclophosphamide ( mecy ) has been shown to be statistically significantly superior to the combination of 5-fluorouracil plus cyclophosphamide ( fucy ) in the treatment of stage iii-iv ovarian adenocarcinoma .
C0010583
cyclophosphamide
C0055160
fluorouracil